Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal cancer: which is better?

doi:10.3877/cma.j.issn.2095-8773.2015.02.002

Abstract

Abstract:

In China, the incidence of esophageal cancer is rather high. For patients with resectable esophageal cancer, surgery is the standard treatment. However, the overall survival of patients with locally advanced esophageal cancer remains low, which highlights why further advances of combined therapy are so desperately needed. Among the multimodality treatments, the most promising strategy to improve the prognosis of advanced esophageal cancer is preoperative chemoradiation followed by surgery. The aim of this article is to provide a complete review of the current status of esophageal cancer treatment with the addition of neoadjuvant chemotherapy and radiotherapy to the surgical management of resectable disease.

Key words: Esophageal cancer, Neoadjuvant therapy, Surgical procedures, Operative

Jianhua FU. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal cancer: which is better?[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2015, 02(02): 83-87.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxbwkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8773.2015.02.002

https://zhxbwkdzzz.cma-cmc.com.cn/EN/Y2015/V02/I02/83

References 25

[1]	平育敏，张毓德，杜喜群，等. 食管癌和贲门癌20000例外科治疗经验[R]. 中国首届国际食管癌学术会议暨第七届全国食管癌学术会议论文集，2005：167-171.
[2]	邵令方，高宗人，许金良，等. 食管癌和贲门癌的外科治疗15707例总结——附河南省食管癌的防治研究概况[R]. 中国首届国际食管癌学术会议暨第七届全国食管癌学术会议论文集，2005：40-45.
[3]	Bhansali M, Vaidya J, Bhatt R, et al. Chemotherapy for carcinoma of the oesophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies[J]. Ann Oncol, 1996, 7(4): 355-359.
[4]	Fok M, McShane J, Law SYK, et al. Prospective randomised study on radiotherapy and surgery in the treatment of oesophageal carcinoma[J]. Asian J Surg, 1994, 17: 223-229.
[5]	Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy for esophageal carcinoma [J]. Cochrane Database Syst Rev, 2005, 4：CD001799.
[6]	Sutton P, Clark P. Neo-adjuvant treatment for oesophageal cancer[J]. GI Cancer, 2000, 11(3): 231-238.
[7]	Hyngstrom JR, Posner MC. Neoadjuvant strategies for the treatment of locally advanced esophageal cancer[J]. J Surg Oncol，2010，101(4)：299-304.
[8]	Berger AC, Farma J, Scott WJ, et al.Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival[J]. J Clin Oncol, 2005，23(19)：4330-4337.
[9]	Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report[J]. J Clin Oncol，1993，11(6): 1118-1123.
[10]	Vallböhmer D, Hölscher AH, DeMeester S, et al. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer[J]. Ann Surg, 2010，252(5)：744-749.
[11]	Schlag P. Randomized trial of preoperative chemothe5rapy for squamous cell carcinoma of the esophagus[J]. Arch Surg, 1992, 127(12): 1446-1450.
[12]	Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial[J]. J Thorac Cardiovasc Surg, 1997, 114(2): 210-217.
[13]	Kelsen D, Ginsber R, Pajak T, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer[J]. N Engl J Med, 1998, 339(27): 1979-1984.
[14]	Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma[J]. Cancer, 2001, 91(11): 2165-2174.
[15]	Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial[J]. Lancet, 2002, 359: 1727-1734.
[16]	Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer[J]. Am J Surg, 2002, 183(3): 274-279.
[17]	Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis[J]. Lancet Oncol, 2011，12(7)：681-692.
[18]	Polee MB, Tilanus HW, Eskens FA, et al. Phase Ⅱ study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus[J]. Ann Oncol, 2003，14(8)：1253-1257.
[19]	Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer[J]. Br J Surg, 2001，88(3): 338-356.
[20]	van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med, 2012，366(22)：2074-2084.
[21]	Yang H, Fu JH, Liu MZ, et al. A phase Ⅲ clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus[J]. J Clin Oncol, 2014, 32：5s (suppl, abstr TPS4146)．
[22]	杨弘，傅剑华，刘孟忠，等．术前放化疗并手术与单纯手术治疗局部晚期食管鳞癌的多中心随机对照临床研究[J] . 中华医学杂志，2012，92(15)：1028-1033.
[23]	Stiles BM, Nasar A, Paul S, et al. Preoperative chemoradiation versus preoperative chemotherapy alone for esophageal cancer: higher response rates but equivalent survival[J]. J Clin Oncol，2014, 32：5s(suppl; abstr 4071)．
[24]	Mariette C, Dahan L, Mornex F, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage Ⅰ and Ⅱ esophageal cancer: final analysis of randomized controlled phase Ⅲ trial FFCD 9901[J]. J Clin Oncol, 2014，32(23)：2416-2422.
[25]	中国抗癌协会食管癌专业委员会. 食管癌规范化诊治指南[M]. 北京：中国协和医科大学出版社，2011.

Please choose a citation manager

Content to export